openPR Logo
Press release

Global somatropin market is growing at moderate space with presence of major players such as Eli Lilly & Company, Pfizer, Regeneron Pharmaceuticals, Sanofi-aventis, Novo Nordisk, Anhui Anke Biotechnology Co., Ltd., Ipsen S.A., GeneScience Pharmaceuticals

02-03-2019 08:02 PM CET | Health & Medicine

Press release from: InsightAce Analytic Pvt. Ltd.

InsightAce Somatropin

InsightAce Somatropin

InsightAce Analytic Pvt. Ltd. announces the release of market assessment report on ' Global Somatropin Market Assessment – Revenue Forecast, Clinical Trial/Pipeline Analysis, Historic Revenue and Forecast Till 2027'

Request for ToC/Proposal: https://bit.ly/2SmyMHb

The synthetic form of human growth hormone is known as somatropin. Until 1985, the growth hormone is obtained through extraction from cadaveric pituitary glands due to its side effect it was discontinued and the first synthetic growth hormone was approved by the U.S. Food Drug Administration in 1985 for the treatment of growth hormone deficiency. It is also approved for the treatment of chronic renal insufficiency, adult growth hormone deficiency, truners syndrome, prader-willi syndrome, idiopathic short stature and Noona syndrome. It is also as anti-aging therapy yet is not approved for this indication. Many synthetic human growth hormone is now available in the market which include Humatrope (Lilly), Nutropin (Genentech), Norditropin (Novo), Genotropin (Pfizer), and Saizen (Merck Serono). As of 2006, the recombinant version of somatroin was lauched a ‘Omnitrope’ by Sandoz. Growing demand for somatropin, led by rising growth hormone deficiency cases and advancement in rDNA technology have boosted the growth of global somatropin market in forecast period. At regional level, the global Somatropin market has been segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. In terms of revenue, North America followed by Europe is major contributor for the global somatropin market.

The somatropin market is fragmented with presence of many players that operates in local as well as international market.
Global somatropin market reports cover prominent players like Sandoz, F. Hoffmann-La Roche AG, Mitsubishi Tanabe Pharma Corporation, Teva Pharmaceutical Industries, Astellas Pharma, Pfizer, Eli Lilly and Company, Novo Nordisk, Anhui Anke Biotechnology Co., Ltd., Ipsen S.A., GeneScience Pharmaceuticals Co., Ltd, Merck co. and many more

Curious about this latest version of report?

Obtain Report Details @ https://bit.ly/2SmyMHb

Market Segments
• Global Somatropin Market Outlook
o Market overview
o Epidemiological data and Forecast
o Pipeline Analysis: Current and Future Market opportunity
o Key Market Trends
o Key Mergers and Acquisitions
o Competition Landscape
o Key News/Industry Activities

• Global Somatropin Market Outlook (Revenue, US$ Mn, 2017 - 2027) By Application
o Chronic Renal Insufficiency
o Growth Hormone Deficiency
o Turners Syndrome
o Prader-Willi Syndrome
o Idiopathic Short Stature
o Noona Syndrome

• Global Somatropin Market Outlook (Revenue, US$ Mn, 2017 - 2027) By Distribution Channel
o Hospital Pharmacy
o Online Pharmacy
o Retail Pharmacy

Why should buy this report:
 To receive a comprehensive analysis of the prospects for global somatropin market
 To receive industry overview and future trends somatropin market
 To analyze the somatropin market drivers and challenges
 To get information on somatropin market size and forecast
 To get details on somatropin clinical trial/pipeline analysis
 Major mergers & acquisition in pharmaceutical industry

For More Information @ https://bit.ly/2SmyMHb

InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Email us: info@insightaceanalytic.com
Call us: +1 718 593 4405
Sagar Arcade, FC Road-Deccan Gymkhana,
Pune, Maharashtra 411004

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global somatropin market is growing at moderate space with presence of major players such as Eli Lilly & Company, Pfizer, Regeneron Pharmaceuticals, Sanofi-aventis, Novo Nordisk, Anhui Anke Biotechnology Co., Ltd., Ipsen S.A., GeneScience Pharmaceuticals here

News-ID: 1555113 • Views:

More Releases from InsightAce Analytic Pvt. Ltd.

High-Temperature Fuel Cells Market Benefits from Technological Advancements and Government Support for Sustainable Power Generation
High-Temperature Fuel Cells Market Benefits from Technological Advancements and …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global High-Temperature Fuel Cells Market- (By Type (Solid Oxide Fuel Cell, Molten Carbonate Fuel Cell, and Others); By Application (Transportation, Distributed Generation and Others)), By Region, Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research by InsightAce Analytic, the Global High-Temperature Fuel Cells Market is expected to grow with a CAGR of
Organic Feminine Care Market to Benefit from Increasing Government Initiatives and Consumer Awareness on Eco-Friendly and Sustainable Products
Organic Feminine Care Market to Benefit from Increasing Government Initiatives a …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Organic Feminine Care Market Size, Share & Trends Analysis Report By Product Type (Sanitary Pads, Tampons, Menstrual Cups, Liners and Shields, Others), by Nature (Disposable, Reusable), by Age Group (Upto 18 Years, 19-30 Years, 31-40 Years, 41 Years and Above), by Distribution Channel (Supermarkets and hypermarkets, Pharmacy, Online Stores, Others)- Market Outlook And Industry Analysis
Intravenous Immunoglobulin Market Key Players Analysis - Biotest AG, Octapharma AG, LFB Biotechnologies, Grifols SA, CSL Behring, China Biologics Products Inc.
Intravenous Immunoglobulin Market Key Players Analysis - Biotest AG, Octapharma …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Intravenous Immunoglobulin Market Size, Share & Trends Analysis Report By Application (Hypogammaglobulinemia, CIDP, Congenital AIDS), By Distribution Channel (hospital pharmacies, speciality pharmacies), Region, Market Outlook And Industry Analysis 2031" The global Intravenous Immunoglobulin market is estimated to reach over USD 21.22 billion by 2031, exhibiting a CAGR of 6.60% during the forecast period. Get Free Access
Exascale Computing Market Key Players Analysis- Hewlett Packard Enterprise Company, International Business Machines Corporation, Intel Corporation, NVIDIA Corporation.
Exascale Computing Market Key Players Analysis- Hewlett Packard Enterprise Compa …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Exascale Computing Market - (By Component (Hardware, Software, Services), By Deployment (On-premises, Cloud-based), By Customer Type (Government & Defense, Healthcare & Biosciences, Financial Services, Research & Academia, Manufacturing & Energy, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research by InsightAce Analytic, the Global Exascale Computing Market is valued at

All 5 Releases


More Releases for Somatropin

Somatropin Market Exclusive Report with Detailed Study Analysis
"Somatropin Market" is poised to grow at a CAGR of 7.5% from 2025 to 2034 according to a new report by InsightAce Analytic. Request For Free Sample Pages: https://www.insightaceanalytic.com/request-sample/1111 Latest Drivers Restraint and Opportunities Market Snapshot: Key factors influencing the somatropin market are: • Raising consciousness on the growth hormone shortage • Increase in cases with insufficient somatropin • Raising consciousness regarding the significance of early detection The following are the primary obstacles to the somatropin market's
Somatropin Market Survey Detailed Analysis and Forecast 2025-2034
"Somatropin Market" is poised to grow at a CAGR of 7.5% from 2025 to 2034 according to a new report by InsightAce Analytic. Request For Free Sample Pages: https://www.insightaceanalytic.com/request-sample/1111 Latest Divers Restraint and Opportunities Market Snapshot: Key factors influencing the somatropin market are: • Raising consciousness on the growth hormone shortage • Increase in cases with insufficient somatropin • Raising consciousness regarding the significance of early detection The following are the primary obstacles to the somatropin market's
Somatropin Market Set to Expand with Rising Adoption in Growth Hormone Deficienc …
Somatropin Market Insights Somatropin Market is estimated to be valued at USD 4.43 Bn in 2025 and is expected to reach USD 7.25 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 7.3% from 2025 to 2032. The qualitative latest Research report (2025-2032) on the Somatropin Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue,
Somatropin Market Deep Research Report Reveals Key Insights - Novo Nordisk, Pfiz …
Somatropin Market Insights Somatropin Market is estimated to be valued at USD 4.43 Bn in 2025 and is expected to reach USD 7.25 Bn in 2032, exhibiting a compound annual growth rate (CAGR) of 7.3% from 2025 to 2032. Coherent Market Insights has published a new comprehensive analysis on the Somatropin Market (2025-2032), focusing on critical transformations in the U.S. healthcare environment. This report highlights essential metrics including market size, revenue forecasts,
Somatropin Market Revenue Report with Forecast to 2031
"Somatropin Market" is poised to grow at a CAGR of 7.38% from 2024 to 2031 according to a new report by InsightAce Analytic. Request For Free Sample Pages: https://www.insightaceanalytic.com/request-sample/1111 Latest Drivers Restraint and Opportunities Market Snapshot: Key factors influencing the somatropin market are: • Raising consciousness on the growth hormone shortage • Increase in cases with insufficient somatropin • Raising consciousness regarding the significance of early detection The following are the primary obstacles to the somatropin market's expansion: • High
Somatropin Market Addressing Growth Deficiencies Beyond Childhood: The Rising De …
Somatotropin Market worth $ 11.33 Billion by 2030 - Exclusive Report by InsightAcea Analytic InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Somatotropin Market- by Application (Chronic Renal Insufficiency, Growth Hormone Deficiency, Turners Syndrome, Prader-Willi Syndrome, Idiopathic Short Stature and Noona Syndrome), Distribution Channel (Hospital Pharmacy, Online Pharmacy and Retail Pharmacy), Trends, Industry Competition Analysis, Revenue and Forecast To 2030." Get a free sample copy